Need help finding what you are looking for?
Contact Us
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480887
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480887
Allogeneic Stem Cells
PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Global Allogeneic Stem Cells Market to Reach $2.4 Billion by 2030
The global market for Allogeneic Stem Cells estimated at US$1.2 Billion in the year 2023, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 10.9% over the period 2023-2030. Regenerative Therapy Application, one of the segments analyzed in the report, is expected to record 11.8% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Drug Discovery & Development Application segment is estimated at 9.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $304.2 Million, While China is Forecast to Grow at 14.5% CAGR
The Allogeneic Stem Cells market in the U.S. is estimated at US$304.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$572.2 Million by the year 2030 trailing a CAGR of 14.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 8.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 33 Featured) -
- Biosolution Co. Ltd.
- Cynata Therapeutics Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Lineage Cell Therapeutics Inc.
- MEDIPOST Co. Ltd.
- MiMedx Group Inc.
- Osiris Therapeutics Inc.
- Stempeutics Research Pvt. Ltd.
- Takeda Pharmaceutical Co. Ltd.;
Product Code: MCP17192
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Allogeneic Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Regenerative Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 10: World Allogeneic Stem Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 11: USA Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 13: USA 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 16: Canada 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- JAPAN
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 17: Japan Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: Japan 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- CHINA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 20: China Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: China Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: China 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- EUROPE
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: Europe 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- FRANCE
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 29: France Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: France Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: France 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- GERMANY
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 32: Germany Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Germany 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: Italy 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 38: UK Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: UK 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- SPAIN
- TABLE 41: Spain Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: Spain Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Spain 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- RUSSIA
- TABLE 44: Russia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Russia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Russia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Rest of Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- AUSTRALIA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 56: Australia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: Australia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: Australia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- INDIA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 59: India Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: India Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: India 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- SOUTH KOREA
- TABLE 62: South Korea Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: South Korea Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: South Korea 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- REST OF ASIA-PACIFIC
- TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Rest of Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- LATIN AMERICA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 68: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 69: Latin America Historic Review for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: Latin America 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 74: Argentina Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: Argentina Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: Argentina 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- BRAZIL
- TABLE 77: Brazil Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Brazil Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Brazil 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- MEXICO
- TABLE 80: Mexico Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: Mexico Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: Mexico 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- REST OF LATIN AMERICA
- TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: Rest of Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: Rest of Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- MIDDLE EAST
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 86: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 87: Middle East Historic Review for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Middle East 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- IRAN
- TABLE 92: Iran Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 93: Iran Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 94: Iran 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- ISRAEL
- TABLE 95: Israel Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 96: Israel Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 97: Israel 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- SAUDI ARABIA
- TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 99: Saudi Arabia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 100: Saudi Arabia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- UNITED ARAB EMIRATES
- TABLE 101: UAE Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 102: UAE Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 103: UAE 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- REST OF MIDDLE EAST
- TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 105: Rest of Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 106: Rest of Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
- AFRICA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 107: Africa Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 108: Africa Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 109: Africa 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
IV. COMPETITION
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.